To better understand the incidence and clinicopathological features of BRAF V600E/K mutation in lung cancer patients of southern Taiwan, a highly sensitive RT-qPCR method was established and 306 lung cancer samples were used for screening. The gene discussed is BRAF; the disease is lung carcinoma.